Screening assays for agonists and antagonists of the hedgehog signaling pathway

• US 7,060,450 B1
• Filed: 11/13/2000
• Issued: 06/13/2006
• Est. Priority Date: 12/30/1993
• Status: Expired due to Fees

• Current Assignee: President and Fellows of Harvard College (Harvard Corporation), Imperial Cancer Research Technology, Ltd.
• Original Assignee: President and Fellows of Harvard College (Harvard Corporation), Imperial Cancer Research Technology, Ltd.
• Inventors: Ingham, Philip W., Tabin, Clifford, Marigo, Valeria, McMahon, Andrew P.
• Primary Examiner(s): Landsman, Robert S.
• Assistant Examiner(s): Howard, Zachary C.
• Application Number:
  US09/711,724
• Time in Patent Office: 2,038 Days
• Field of Search: 435/7.1, 435/7.2, 435/7.21, 435/69.1, 435/325, 435/348, 435/320.1, 435/248, 435/252.3, 435/254.2, 536/23.1, 536/23.5, 530/350
• US Class Current: 435/7.21
• CPC Class Codes: A01K 2217/05 Animals comprising random inserted nucleic acids (transgenic)
• CPC Class Codes: A01K 2227/706 Insects, e.g. Drosophila melanogaster, medfly
• CPC Class Codes: A01K 2267/03 Animal model, e.g. for test or diseases
• CPC Class Codes: A01K 67/0339 Genetically modified insects, e.g. Drosophila melanogaster, medfly
• CPC Class Codes: C07K 14/4702 Regulators; Modulating activity
• CPC Class Codes: C12N 2830/008 cell type or tissue specific enhancer/promoter combination
• CPC Class Codes: G01N 2500/02 Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
• CPC Class Codes: G01N 2500/10 involving cells
• CPC Class Codes: G01N 33/5008 for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
• CPC Class Codes: G01N 33/5041 involving analysis of members of signalling pathways
• CPC Class Codes: G01N 33/5088 of vertebrates
• CPC Class Codes: G01N 33/68 involving proteins, peptides or amino acids involving lipoproteins G01N33/92

Abstract

The present invention concerns the discovery that proteins encoded by a family of vertebrate genes, termed here hedgehog-related genes, comprise morphogenic signals produced by embryonic patterning centers, and are involved in the formation of ordered spatial arrangements of differentiated tissues in vertebrates. The present invention makes available compositions and methods that can be utilized, for example to generate and/or maintain an array of different vertebrate tissue both in vitro and in vivo.

Claims

1. An assay for identifying compounds that mimic a bioactivity of a hedgehog protein, comprising:

(a) providing a cell that transduces intracellular signals of the hedgehog pathway and that expresses a naturally occurring patched protein;

(b) contacting the cell with a test compound; and

(c) detecting activation of the hedgehog pathway in the cell by detecting a change in GLI expression in the cell, which GLI expression is responsive to the hedgehog pathway;

wherein a change in the activation of the hedgehog pathway in the presence of the test compound, relative to the activation in the absence of the test compound, indicates a hedgehog-mimicking bioactivity for the test compound.

2. The assay of claim 1, wherein the cell includes a heterologous nucleic acid recombinantly expressing the patched protein.

3. The assay of claim 2, wherein the recombinant cell lacks expression of an endogenous patched protein.

9. The assay of claim 1 or 7, wherein the patched protein is of vertebrate origin.

10. The assay of claim 9, wherein the patched protein is a mammalian patched protein.

11. The assay of claim 10, wherein the patched protein is a human patched protein.

22. The assay of claims 1, 4, 7, 12, or 13, wherein the test compound is selected from small organic molecules or natural product extracts.

23. The assay of claim 1, 4, 7, 12, or 13 further comprising preparing a pharmaceutical preparation by combining one or more compounds identified with a biologically acceptable medium.

4. An assay for identifying compounds that mimic a bioactivity of a hedgehog protein, comprising:

(a). providing a cell expressing a naturally occurring patched protein, which cell transduces intracellular signals of the hedgehog pathway, wherein said patched protein binds a naturally occurring hedgehog protein;

(b). contacting the cell with a test compound; and

(c). detecting activation of the hedgehog pathway in the cell, by detecting an increase in the expression of the GLI gene in the cell or a decrease in the expression of the GLI3 gene in the cell, which GLI expression is responsive to the hedgehog pathway,

wherein a change in the level of activation of the hedgehog pathway is indicative of a compound that mimics a bioactivity of a hedgehog protein.

5. The assay of claim 4, wherein the cell further comprises a heterologous gene construct encoding the patched protein.

6. The assay of claim 4, wherein the cell further comprises one or more heterologous gene constructs encoding and expressing costal-2, fused and/or smoothened genes.

7. An assay for identifying compounds that activate the hedgehog pathway, comprising:

(a). providing a cell having a recombinant expression vector encoding a naturally occurring mammalian patched protein, wherein said cell transduces intracellular signals of the hedgehog pathway;

(b). contacting the cell with a test compound under conditions wherein the patched protein is expressed; and

(c). detecting a change in the hedgehog pathway in the cell, by detecting an increase in the expression of the GLI gene in the cell or a decrease in the expression of the GLI3 gene in the cell, which GLI expression is responsive to the hedgehog pathway,

wherein a change in the level of activation of the hedgehog pathway in the presence of the test compound, relative to in the absence of the test compound, is indicative of an agent that activates the hedgehog pathway.

8. The assay of claim 7, wherein the cell is a human cell.

12. An assay for identifying compounds that antagonize the hedgehog pathway, comprising:

(a) providing a cell expressing a naturally occurring patched protein, which cell transduces intracellular signals of the hedgehog pathway and wherein said patched protein binds a naturally occurring hedgehog protein;

(b) contacting the cell with a test compound;

(c) detecting a change in the level of activation of the hedgehog pathway in said cell in the presence of said test compound by detecting a change in GLI or GLI3 expression in the cell, in which GLI or GLI3 expression is responsive to the hedgehog pathway,

wherein a decrease in the expression of the GLI gene in the cell or an increase in the expression of the GLI3 gene in the cell in the presence of said test compound in comparison to the absence of said test compound is indicative of a decrease in the level of activation of the hedgehog pathway, and thus is indicative of a compound that antagonizes the hedgehog pathway.

14. A method of claim 12 or 13, wherein said cells are transfected to express a recombinant form of the patched protein.

15. A method of claim 12 or 13, wherein said cells are eukaryotic.

16. A method of claim 15, wherein said cells are vertebrate cells.

17. A method of claim 16, wherein said cells are mammalian cells.

18. The assay of any of claims 2, 4, 7, 12, wherein the cell is a metazoan cell.

19. The assay of claim 18, wherein the cell is a mammalian cell.

20. The assay of claim 18, wherein the cell is an insect cell.

21. The assay of claim 4, 7, 12, or 13, wherein the steps of the assay are repeated to screen a library of at least 100 different test compounds.

13. A method for identifying hedgehog pathway antagonists, comprising:

contacting a test compound with cells expressing a naturally occurring patched protein, which cells transduce intracellular signals of the hedgehog pathway and wherein said cells undergo a detectable response when contacted with a naturally occurring hedgehog protein; and

comparing the response of said cells to the test compound with the response of similar cells to a naturally occurring hedgehog protein, which detectable response is a change in GLI expression in the cell, wherein a decrease in the detectable response in the presence of the test compound in comparison to the detectable response induced in the presence of the hedgehog protein indicates antagonist activity of the test compound to the hedgehog pathway.

24. A method for identifying hedgehog pathway agonists, comprising:

contacting a test agent with cells expressing a naturally occurring patched protein, which cells transduce intracellular signals of the hedgehog pathway and wherein said cells undergo a detectable response when contacted with a naturally occurring hedgehog protein; and

comparing the response of said cells to the test agent with the response of similar cells to a naturally occurring hedgehog protein, which detectable response is a change in GLI expression in the cell, wherein induction of a response in the presence of the test agent similar to the response induced in the presence of the hedgehog protein is indicative of agonist activity of the test agent to the hedgehog pathway.

25. A method of claim 24, wherein said cells are transfected to express a recombinant form of the patched protein.

26. A method of claim 24 or 25, wherein said cells are eukaryotic.

27. A method of claim 26, wherein said cells are vertebrate cells.

28. A method of claim 26, wherein said cells are mammalian cells.

29. An assay for identifying compounds that antagonize the hedgehog pathway, comprising:

(a) providing a cell expressing a naturally occurring patched protein, which cell transduces intracellular signals of the hedgehog pathway and wherein said patched protein binds a naturally occurring hedgehog protein;

(b) contacting the cell with a test compound;

(c) detecting a change in the level of activation of the hedgehog pathway in said cell by detecting a decrease in the expression of the GLI gene in the cell or an increase in the expression of the GLI3 gene in the cell in the presence of said test compound, in which GLI or GLI3 expression is responsive to the hedgehog pathway,

wherein a decrease in the level of activation of the hedgehog pathway in the presence of said test compound in comparison to the absence of said test compound is indicative of a compound that antagonizes the hedgehog pathway.